- Home
- ADMA vs TFPM Comparison
ADMA vs TFPM Comparison
Compare ADMA & TFPM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADMA
- TFPM
- Stock Information
- Founded
- ADMA 2004
- TFPM 2016
- Country
- ADMA United States
- TFPM Canada
- Employees
- ADMA N/A
- TFPM N/A
- Industry
- ADMA Biotechnology: Biological Products (No Diagnostic Substances)
- TFPM Precious Metals
- Sector
- ADMA Health Care
- TFPM Industrials
- Exchange
- ADMA Nasdaq
- TFPM Nasdaq
- Market Cap
- ADMA 3.8B
- TFPM 3.3B
- IPO Year
- ADMA N/A
- TFPM N/A
- Fundamental
- Price
- ADMA $16.90
- TFPM $16.42
- Analyst Decision
- ADMA Strong Buy
- TFPM Strong Buy
- Analyst Count
- ADMA 4
- TFPM 4
- Target Price
- ADMA $21.25
- TFPM $20.50
- AVG Volume (30 Days)
- ADMA 2.5M
- TFPM 208.8K
- Earning Date
- ADMA 02-26-2025
- TFPM 01-01-0001
- Dividend Yield
- ADMA N/A
- TFPM 1.34%
- EPS Growth
- ADMA N/A
- TFPM N/A
- EPS
- ADMA 0.28
- TFPM N/A
- Revenue
- ADMA $382,809,000.00
- TFPM $246,517,000.00
- Revenue This Year
- ADMA $66.90
- TFPM $34.53
- Revenue Next Year
- ADMA $13.76
- TFPM $11.05
- P/E Ratio
- ADMA $60.29
- TFPM N/A
- Revenue Growth
- ADMA 63.39
- TFPM 25.66
- 52 Week Low
- ADMA $5.02
- TFPM $11.75
- 52 Week High
- ADMA $23.64
- TFPM $18.88
- Technical
- Relative Strength Index (RSI)
- ADMA 48.60
- TFPM 60.69
- Support Level
- ADMA $15.70
- TFPM $15.86
- Resistance Level
- ADMA $16.60
- TFPM $16.40
- Average True Range (ATR)
- ADMA 0.69
- TFPM 0.36
- MACD
- ADMA 0.10
- TFPM 0.09
- Stochastic Oscillator
- ADMA 77.17
- TFPM 91.90
About ADMA ADMA Biologics Inc
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.
About TFPM Triple Flag Precious Metals Corp.
Triple Flag Precious Metals Corp is a precious-metals-focused streaming and royalty company. Its revenues are largely generated from a diversified portfolio of properties in Australia, Canada, Colombia, Cote d'Ivoire, Honduras, Mexico, Mongolia, Peru, South Africa, and the United States.